443 related articles for article (PubMed ID: 9579633)
1. Pharmacological actions of sulodexide.
Ofosu FA
Semin Thromb Hemost; 1998; 24(2):127-38. PubMed ID: 9579633
[TBL] [Abstract][Full Text] [Related]
2. Antithrombotic activity of dermatan sulphates, heparins and their combination in an animal model of arterial thrombosis.
Iacoviello L; D'Adamo MC; Pawlak K; Polishchuck R; Wollny T; Buczko W; Donati MB
Thromb Haemost; 1996 Dec; 76(6):1102-7. PubMed ID: 8972038
[TBL] [Abstract][Full Text] [Related]
3. Mechanisms for the anticoagulant effect of heparin and related polysaccharides.
Ofosu FA
Nouv Rev Fr Hematol (1978); 1988; 30(3):155-60. PubMed ID: 2971155
[TBL] [Abstract][Full Text] [Related]
4. Antithrombotic and anticomplementary properties of a very low molecular mass dermatan sulfate.
Fabiana Alberto M; Giaquinta Romero D; Lazzari M; Calabrese GC
Thromb Res; 2008; 122(1):109-16. PubMed ID: 17936880
[TBL] [Abstract][Full Text] [Related]
5. An algal sulfated galactan has an unusual dual effect on venous thrombosis due to activation of factor XII and inhibition of the coagulation proteases.
Melo FR; Mourão PA
Thromb Haemost; 2008 Mar; 99(3):531-8. PubMed ID: 18327401
[TBL] [Abstract][Full Text] [Related]
6. Fucosylated chondroitin sulfate as a new oral antithrombotic agent.
Fonseca RJ; Mourão PA
Thromb Haemost; 2006 Dec; 96(6):822-9. PubMed ID: 17139379
[TBL] [Abstract][Full Text] [Related]
7. Unbalanced effects of dermatan sulfates with different sulfation patterns on coagulation, thrombosis and bleeding.
Vicente CP; Zancan P; Peixoto LL; Alves-Sá R; Araújo FS; Mourão PA; Pavão MS
Thromb Haemost; 2001 Nov; 86(5):1215-20. PubMed ID: 11816710
[TBL] [Abstract][Full Text] [Related]
8. Pharmacologic properties of a low molecular weight dermatan sulfate: comparison with unfractionated dermatan sulfate.
Dol F; Petitou M; Lormeau JC; Choay J; Caranobe C; Sie P; Saivin S; Houin G; Boneu B
J Lab Clin Med; 1990 Jan; 115(1):43-51. PubMed ID: 2299256
[TBL] [Abstract][Full Text] [Related]
9. [Dermatan sulfate and the prevention of experimental venous thrombosis].
Desnoyers P; Bara L; Samama M
Pathol Biol (Paris); 1989 Jun; 37(6):759-67. PubMed ID: 2674877
[TBL] [Abstract][Full Text] [Related]
10. Different antithrombotic mechanisms among glycosaminoglycans revealed with a new fucosylated chondroitin sulfate from an echinoderm.
Pacheco RG; Vicente CP; Zancan P; Mourão PA
Blood Coagul Fibrinolysis; 2000 Sep; 11(6):563-73. PubMed ID: 10997797
[TBL] [Abstract][Full Text] [Related]
11. Pharmacological profile of sulodexide.
Hoppensteadt DA; Fareed J
Int Angiol; 2014 Jun; 33(3):229-35. PubMed ID: 24936531
[TBL] [Abstract][Full Text] [Related]
12. A survey of the clinical experience with dermatan sulfate.
Gianese F; Lucchelli PE
Semin Thromb Hemost; 1991; 17 Suppl 2():199-204. PubMed ID: 1948090
[No Abstract] [Full Text] [Related]
13. Pharmacological properties of dermatan sulfate, of a low molecular weight dermatan sulfate and of two oversulfated derivatives.
Dol F; Petitou M; Choay J; Sie P; Houin G; Boneu B
Folia Haematol Int Mag Klin Morphol Blutforsch; 1989; 116(6):851-7. PubMed ID: 2483702
[TBL] [Abstract][Full Text] [Related]
14. Effects of polysaccharides enriched in 2,4-disulfated fucose units on coagulation, thrombosis and bleeding. Practical and conceptual implications.
Fonseca RJ; Santos GR; Mourão PA
Thromb Haemost; 2009 Nov; 102(5):829-36. PubMed ID: 19888516
[TBL] [Abstract][Full Text] [Related]
15. Additive thrombin inhibition by fast moving heparin and dermatan sulfate explains the anticoagulant effect of sulodexide, a natural mixture of glycosaminoglycans.
Cosmi B; Cini M; Legnani C; Pancani C; Calanni F; Coccheri S
Thromb Res; 2003 Mar; 109(5-6):333-9. PubMed ID: 12818259
[TBL] [Abstract][Full Text] [Related]
16. Rationale behind the development of low molecular weight heparin derivatives.
Hirsh J; Ofosu F; Buchanan M
Semin Thromb Hemost; 1985 Jan; 11(1):13-6. PubMed ID: 2579436
[TBL] [Abstract][Full Text] [Related]
17. Slight differences in sulfation of algal galactans account for differences in their anticoagulant and venous antithrombotic activities.
Fonseca RJ; Oliveira SN; Melo FR; Pereira MG; Benevides NM; Mourão PA
Thromb Haemost; 2008 Mar; 99(3):539-45. PubMed ID: 18327402
[TBL] [Abstract][Full Text] [Related]
18. Pharmacological and clinical studies with Lomoparan, a low molecular weight glycosaminoglycan.
Nurmohamed MT; Fareed J; Hoppensteadt D; Walenga JM; ten Cate JW
Semin Thromb Hemost; 1991; 17 Suppl 2():205-13. PubMed ID: 1948091
[No Abstract] [Full Text] [Related]
19. Dual effects of sulfated D-galactans from the red algae Botryocladia occidentalis preventing thrombosis and inducing platelet aggregation.
Farias WR; Nazareth RA; Mourão PA
Thromb Haemost; 2001 Dec; 86(6):1540-6. PubMed ID: 11776325
[TBL] [Abstract][Full Text] [Related]
20. Effects of heparin, dermatan sulfate and of their association on the inhibition of venous thrombosis growth in the rabbit.
Carrie D; Caranobe C; Gabaig AM; Larroche M; Boneu B
Thromb Haemost; 1992 Dec; 68(6):637-41. PubMed ID: 1287877
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]